Literature DB >> 17446842

Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties.

Shanmiao Gou1, Tao Liu, Chunyou Wang, Tao Yin, Kai Li, Ming Yang, Jing Zhou.   

Abstract

OBJECTIVE: Pancreatic cancer is among the most aggressive solid malignancies. It is possible that pancreatic cancer contains cancer stem cells responsible for its malignancy. The purposes of this study were (1) to establish an assay in which a subset of pancreatic cancer cell line (PANC-1) cells with stem cell properties can propagate, and (2) to identify the cells obtained from this assay.
METHODS: The PANC-1 cells were cultured in Dulbecco modified eagle medium F12 supplemented with epidermal growth factor, basic fibroblast growth factor, insulin, transferrin, selenium, and bovine serum albumin at a density of 1000 cells/mL for 10 to 14 days to form spheres. Cells of spheres were cultured in different conditions to evaluate their ability of self-renewal and differentiation. Clone formation assay and tumor formation assay were used to identify the ability of propagation in vitro and in vivo. The cells and spheres were also stained by using Hoechst 33342 dye to evaluate their capacity of excluding Hoechst dye. Real-time polymerase chain reaction was used to detect expressions of LY6E, c-Met, TACSTD1, CD34, and CD44 mRNA.
RESULTS: A subpopulation of PANC-1 cells could propagate to form spheres in this assay. Cells of obtained spheres had the hallmark of excluding Hoechst 33342 dye. Cultured in serum-free medium, the dissociated single cells of primary spheres could form filial spheres again; cultured in serum-containing medium, these cells generated both the cells with the ability of excluding Hoechst 33342 dye and the cells without that ability. The propagation capacity of PANC-1 spheres was higher than that of cells cultured in serum-containing medium both in vitro and in vivo. In addition, LY6E, TACSTD1, and CD44 mRNA were overexpressed in PANC-1 spheres.
CONCLUSIONS: A subpopulation of PANC-1 cells can propagate to form spheres with properties of stem cells in this assay; enough of these cells can be obtained for further study. Considering the overexpression of mRNA, it was tentatively suggested that LY6E, TACSTD1, and CD44 proteins may act as surface markers for sorting pancreatic cancer stem cells with fluorescence-activated cell sorter/magnetic-activated cell sorter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446842     DOI: 10.1097/MPA.0b013e318033f9f4

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  67 in total

1.  Increased expression of DNA repair genes in invasive human pancreatic cancer cells.

Authors:  Lesley A Mathews; Stephanie M Cabarcas; Elaine M Hurt; Xiaohu Zhang; Elizabeth M Jaffee; William L Farrar
Journal:  Pancreas       Date:  2011-07       Impact factor: 3.327

2.  Emerging strategies for the identification and targeting of cancer stem cells.

Authors:  Jun Dou; Ning Gu
Journal:  Tumour Biol       Date:  2010-03-25

Review 3.  Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.

Authors:  M Mimeault; S K Batra
Journal:  Gut       Date:  2008-10       Impact factor: 23.059

4.  The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells.

Authors:  Simone Brabletz; Karolina Bajdak; Simone Meidhof; Ulrike Burk; Gabriele Niedermann; Elke Firat; Ulrich Wellner; Arno Dimmler; Gerhard Faller; Jörg Schubert; Thomas Brabletz
Journal:  EMBO J       Date:  2011-01-11       Impact factor: 11.598

Review 5.  Pancreatic cancer stem cells: features and detection methods.

Authors:  Toshiyuki Ishiwata; Yoko Matsuda; Hisashi Yoshimura; Norihiko Sasaki; Shunji Ishiwata; Naoshi Ishikawa; Kaiyo Takubo; Tomio Arai; Junko Aida
Journal:  Pathol Oncol Res       Date:  2018-06-08       Impact factor: 3.201

Review 6.  Pancreatic cancer stem cells: fact or fiction?

Authors:  Vikash J Bhagwandin; Jerry W Shay
Journal:  Biochim Biophys Acta       Date:  2009-02-21

7.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.

Authors:  Ulrich Wellner; Jörg Schubert; Ulrike C Burk; Otto Schmalhofer; Feng Zhu; Annika Sonntag; Bettina Waldvogel; Corinne Vannier; Douglas Darling; Axel zur Hausen; Valerie G Brunton; Jennifer Morton; Owen Sansom; Julia Schüler; Marc P Stemmler; Christoph Herzberger; Ulrich Hopt; Tobias Keck; Simone Brabletz; Thomas Brabletz
Journal:  Nat Cell Biol       Date:  2009-11-22       Impact factor: 28.824

8.  Modeling pancreatic cancer with organoids.

Authors:  Lindsey A Baker; Hervé Tiriac; Hans Clevers; David A Tuveson
Journal:  Trends Cancer       Date:  2016-04

9.  Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells.

Authors:  Lei Sun; Lesley A Mathews; Stephanie M Cabarcas; Xiaohu Zhang; Acong Yang; Ying Zhang; Matthew R Young; Kimberly D Klarmann; Jonathan R Keller; William L Farrar
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

10.  67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis.

Authors:  Motofumi Kumazoe; Kaori Sugihara; Shuntaro Tsukamoto; Yuhui Huang; Yukari Tsurudome; Takashi Suzuki; Yumi Suemasu; Naoki Ueda; Shuya Yamashita; Yoonhee Kim; Koji Yamada; Hirofumi Tachibana
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.